$21.66
1.497.39%
Last update: Nov 4, 7:50 PM

The average analyst price target for PROCEPT BioRobotics is $34.17, 76.9% above the current price. Of 14 analysts, 6 rate it Buy, 7 Hold and 1 Sell. Targets range from $20 to $95. The latest change came on Oct 7, 2026, when Barclays initiated coverage of PROCEPT BioRobotics with an Overweight rating and a $30 price target.
Price Target Range — 13 Quarters
Analyst Consensus — 14 Analysts
Rating Trend — Last 9 Months